HCP Registration Form
Back to: Farydak Now Approved
Brand: Farydak (panobinostat), Capsules
Parent Company: Novartis
Drug Type: Boxed Warning
Drug Category: Oncology
Campaign: now-approved
Targeting: HCPs, Patients
Patient Website: https://www.us.farydak.com/
HCP Website: https://www.hcp.novartis.com/products/farydak/multiple-myeloma/
Parent Company: Novartis
Drug Type: Boxed Warning
Drug Category: Oncology
Campaign: now-approved
Targeting: HCPs, Patients
Patient Website: https://www.us.farydak.com/
HCP Website: https://www.hcp.novartis.com/products/farydak/multiple-myeloma/